drugset / Trial / NCT02417935
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to evaluate the effectiveness and safety of the study drug known as duloxetine in participants with diabetic peripheral neuropathic pain.
Timeline
- Start
- 2015-04
- Primary completion
- 2017-05-13
- Completion
- 2017-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 40 mg | Oral |
| Subject | Duloxetine | Small molecule | 60 mg | Oral |
| Comparator | Pregabalin | Small molecule | 300 mg | Oral |
| Comparator | Pregabalin | Small molecule | 600 mg | Oral |